High out-of-pocket (OOP) costs for heart failure (HF) management continue to create confusion, financial burdens, financial strain and financial toxicity for patients with chronic diseases in the U.S., leading to poor medication adherence and negative health outcomes, authors share in a state-of-the-art review.